VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $315,000 | +4.0% | 3,100 | +82.4% | 0.13% | 0.0% |
| Q3 2015 | $303,000 | -19.8% | 1,700 | 0.0% | 0.13% | -12.5% |
| Q2 2015 | $378,000 | +11.8% | 1,700 | 0.0% | 0.14% | +20.0% |
| Q1 2015 | $338,000 | +39.1% | 1,700 | 0.0% | 0.12% | +42.9% |
| Q4 2014 | $243,000 | +9.0% | 1,700 | 0.0% | 0.08% | +3.7% |
| Q3 2014 | $223,000 | +4.2% | 1,700 | 0.0% | 0.08% | +9.5% |
| Q2 2014 | $214,000 | -4.5% | 1,700 | 0.0% | 0.07% | -7.5% |
| Q1 2014 | $224,000 | – | 1,700 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |